Clinical features of adult-onset chronic active Epstein–Barr virus infection: a retrospective analysis
- 14 April 2011
- journal article
- case report
- Published by Springer Nature in International Journal of Hematology
- Vol. 93 (5) , 602-609
Abstract
We performed a retrospective analysis of patients with adult-onset chronic active Epstein–Barr virus infection (CAEBV). First, we analyzed five patients (aged 28–72) diagnosed at our hospitals with EBV-infected clonally proliferating T cells. Four patients were administered cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) chemotherapy, but no remarkable decrease of viral load was observed in three of the patients. The other patient died 19 days after initiation of CHOP treatment due to disease progression. Addition of high-dose cytarabine to the regimens of two of the patients was discontinued shortly after administration, due to the development of grade 4 pericardial effusion. Together, these regimens may be insufficient for treating adult-onset CAEBV. We next reviewed 23 adult-onset CAEBV patients, adding 18 previously reported patients to the five patients described in the present study. T cells were frequently infected (87%), whereas NK- and T-cell types are known to be almost equally prevalent in childhood-onset cases. The time duration from the onset of disease to initiation of treatment averaged 20 months. Reports showed that 12 patients died; seven patients died at an average of 8 months after initiation of treatment. Patients’ disease courses seemed to be rapidly progressive and more aggressive than those of childhood-onset cases. More cases must be studied to clarify clinical features and establish an optimal treatment strategy.Keywords
This publication has 24 references indexed in Scilit:
- M-protein-positive chronic active Epstein–Barr virus infection: features mimicking HIV-1 infectionInternational Journal of Hematology, 2009
- Clinical and Virological Characteristics of 15 Patients with Chronic Active Epstein‐Barr Virus Infection Treated with Hematopoietic Stem Cell TransplantationClinical Infectious Diseases, 2008
- Proposed categorization of pathological states of EBV‐associated T/natural killer‐cell lymphoproliferative disorder (LPD) in children and young adults: Overlap with chronic active EBV infection and infantile fulminant EBV T‐LPDPathology International, 2008
- Proposed guidelines for diagnosing chronic active Epstein‐Barr virus infectionAmerican Journal of Hematology, 2005
- Generalized myositis mimicking polymyositis associated with chronic active Epstein-Barr virus infectionJournal of Neurology, 2005
- Complete resolution of severe chronic active Epstein–Barr virus infection by cultured, activated donor T lymphocyte infusion after nonmyeloablative stem cells allograftingBone Marrow Transplantation, 2003
- An autopsied case of chronic active Epstein-Barr virus infection complicated in systemic lupus erythematosus and antiphospholipid antibody syndrome.Japanese Journal of Clinical Immunology, 2002
- Clinical and virologic characteristics of chronic active Epstein-Barr virus infectionBlood, 2001
- Fatal atypical T‐cell proliferation associated with Epstein–Barr virus infectionBritish Journal of Haematology, 2001
- Allogeneic peripheral blood stem cell transplantation for the treatment of chronic active Epstein–Barr virus infectionBone Marrow Transplantation, 2000